The purpose of this study is to investigate gastro-enteric-pancreatic neuroendocrine tumors. This study collects data on how these tumors are diagnosed, treated, and monitored in patients in Italy.
The study evaluates the effectiveness of creating a national database for data collection. It focuses on ensuring the data is collected, updated, and managed properly to maintain important clinical information.
- Who can participate: Adults aged 18 and older with a confirmed diagnosis of NET or supported by specific imaging tests. Participants must have a diagnosis of GEP-NET within one year of signing the informed consent.
- Study details: Participants will agree to share their medical data with ITANET. The data will be collected in a secure way, and each patient will be identified by a code.